Patent · US Active

Inhibitors of the HIV integrase enzyme

US7692014B2 · kind B2 · utility

0Cited by
12References
4Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 25, 2005
Grant dateApr 6, 2010
Priority date
Expiry dateOct 30, 2027

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D471/14
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The present invention is directed to compounds of formula (I),and pharmaceutically acceptable salts and solvates thereof, their synthesis, and their use as modulators or inhibitors of the human immunodeficiency virus (“HIV”) integrase enzyme.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.